The global external ventricular drain market size was valued at USD 6.54 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.9% from 2023 to 2030. The rising incidences of neurological disorders and road accidents that result in traumatic brain injuries are major factors driving the market for external ventricular drains. In addition, increasing research activities and rising adoption of technologically advanced products are few other factors contributing towards market growth.
According to the World Health Organization (WHO), neurovascular stroke is the second most common cause of death, and the third most common cause of disability around the world, with approximately 60-80% of all strokes being ischemic. This occurs due to blocked blood vessels, which limit the blood supply to the brain, or when a weakened blood vessel bursts and bleeds into the surrounding brain. Since the last few years, the incidence rate of strokes, majorly in low- and middle-income countries, has more than doubled. For instance, India has a very high incidence rate of ischemic stroke, which is one of the leading causes of death.
A study published in Neurology India found that India faces a high stroke burden, with ischemic stroke being the most common, accounting for 80% of the total cases. According to data published by Stroke Forum, over 13.7 million new strokes are reported, and nearly six million people die annually due to stroke. In addition, around 1.1 million people in Europe suffer from ischemic stroke every year. Thus, a high incidence of cerebrovascular disorders may lead to intraventricular bleeding (hemorrhage), which in turn demands the use of ventricular drain sets to remove excess cerebrospinal fluid. This is expected to drive the market for external ventricular drain over the forecast period.
Moreover, the increasing incidence rate of cranial injuries and trauma worldwide is a key driver of the market for external ventricular drain. Road accidents falls and sports injuries are the most common causes of head trauma and cranial injuries. This results in hospitalization and a potential permanent disability for thousands of individuals every year. Raised intracranial pressure (ICP) after a head injury is considered to have an adverse effect with a mortality rate of around 20%. Thus, the continuous monitoring of intracranial pressure is crucial to map the progression of brain injury.
According to the World Health Organization (WHO), vehicle injuries are projected to be the ninth leading cause of death worldwide. Road traffic crashes cause 1.3 million deaths annually and 20-50 million non-fatal injuries globally. These growing incidences are anticipated to boost the demand for external ventricular drains for treatment.
Rising demand for minimally or noninvasive neurosurgeries to help lower trauma and realize better patient outcomes is projected to accelerate the growth of the market. The growing demand is also due to minimal pain, high cost-efficiency, safety, efficacy, and rapid recovery than traditional procedures. In addition, minimally invasive neurovascular surgeries involve fewer interruptions of adjacent tissues, making the procedure easier and more natural. Additionally, increasing concerns for natural appearance and aesthetics and less blood loss during surgeries are driving the market for external ventricular drain.
Countries such as the U.S. and Canada have witnessed a high prevalence rate of neurovascular disorders and traumatic brain injuries. Explosive blasts or gunshot exposure are common causes of brain-related injuries in military personnel. For instance, as per the Defense and Veterans Brain Injury Center (DVBIC), around 414,000 TBIs have been reported among U.S. service members between 2000 and late 2019.
On average, about 1,600 TBIs per month are suffered by U.S. service members. Furthermore, as per the Brain Injury Association of Waterloo-Wellington (BIAWW), every year in Canada, over 11,000 people die due to TBIs, and more than 6,000 become permanently disabled post-TBIs. Thus, the increasing incidence of neurovascular disorders and brain injuries leads to an increase in the number of brain surgeries. This is anticipated to boost the market growth for external ventricular drains over the forecast period.
Additionally, the growing awareness regarding neurological illnesses such as hemorrhage, vascular malformations, strokes, and intracranial vascular stenosis is anticipated to create growth opportunities in the market for external ventricular drains. For instance, in September 2022, the Indian Institute of Technology, Mandi, and PGIMER, Chandigarh, collaborated to develop a portable, cost-effective device for detecting and diagnosing strokes caused by impaired blood flow to the brain.
Governments of various countries have launched several initiatives and programs to improve public awareness and treatment related to neurological conditions such as ischemic stroke. For instance, the Department of Health and Human Services in the U.S. has launched an initiative to control the incidence of stroke. This program involves activities to reduce the risk of disorders causing stroke and improve the overall health of the people. Such initiatives to raise awareness regarding neurovascular disorders and conditions are collectively driving the market for external ventricular drain.
The traumatic brain injury segment dominated the external ventricular drain market with a revenue share of 33.8% in 2022. This segment is also expected to expand at the fastest CAGR of 5.9% during the forecast period. The increasing prevalence of traumatic brain injuries due to road accidents, falls, and violence is contributing to the segment growth. Such injuries lead to hospitalization and permanent disability for thousands of individuals each year.
For instance, as per the European Injury Database (IDB), approximately 6.1 million people are treated in hospitals for injuries every year. These injuries include facial and traumatic brain injuries. Similarly, according to a CDC report, an estimated 56,000 seniors are hospitalized every year as a result of head injuries suffered due to falls, and 775,000 older adults are living with traumatic brain injury-related disabilities. This is expected to fuel segment growth during the forecast period.
The Centers for Disease Control and Prevention states that ischemic stroke occurs when the blood clots and blocks brain vessels. According to Stroke Forum data, of all possible strokes, 88% of the cases are ischemic strokes and 12% are hemorrhagic strokes. Moreover, more than 2.7 million people die from ischemic stroke globally each year, according to the World Stroke Organization.
Furthermore, conditions such as hydrocephalus affect a large number of people across the world. For instance, as per the Hydrocephalus Association, over 1.0 million people are currently suffering from the condition in the U.S., which is the most common reason for brain surgeries. Similarly, over 750,000 people in America are living with normal pressure hydrocephalus (NPH). It is estimated that more than 400,000 babies suffer from infant hydrocephalus each year globally.
Such a high prevalence of neurovascular disorders, along with the rising number of brain surgeries, is expected to boost the growth of the market for external ventricular drains during the forecast period. According to the Centers for Disease Control and Prevention (CDC), the death rate due to stroke increased from 38.8 per 100,000 in 2020 to 41.1 per 100,000 in 2021.
The adult segment accounted for the largest revenue share of 88.5% in 2022. The prevalence of hydrocephalus has risen dramatically over time, driving the demand for EVD devices as a viable treatment option in adults. The increasing frequency of neurological illnesses due to road accidents, falls, and violence, all contribute to the rapid expansion in demand for external ventricular drains. For instance, as per the European Injury Database (IDB), approximately 6.1 million people are treated in hospitals for injuries every year. These injuries include facial and traumatic brain injuries.
The pediatric segment is expected to witness a growth rate of 6.0% through 2030 due to an increase in surgical procedures for treating hydrocephalus in newborns. According to a report published by Pediatric Neurosurgery, around 69,000 patients are reported annually in the U.S. Hydrocephalus affects 1-2 out of every 1,000 infants, as per the National Institute of Neurological Disorders and Stroke (NINDS). When the flow of cerebrospinal fluid inside the brain is impeded, an external ventricular drain device is used to treat and alleviate elevated intracranial pressure and hydrocephalus.
North America dominated the market for external ventricular drain with a revenue share of 35.4% in 2022. This is owing to the greater incidence of traumatic brain injuries in the region, as well as a high prevalence of neurovascular disorders. For instance, as per the CDC, stroke is the fifth leading cause of death in the country, with more than 140,000 people being killed due to cerebrovascular stroke each year
According to the American Stroke Association, around 2.5 million people have multiple sclerosis, whereas 10 million have Parkinson's disease worldwide. Spinal cord injuries can also affect the nervous system, leading to disabilities, which depend on the injury. According to the WHO, globally, between 250,000 to 500,000 people suffer a spinal cord injury every year.
In the Middle East & Africa (MEA), the market for external ventricular drain is expected to witness the fastest CAGR of 6.5% during the forecast period. This is due to the presence of a huge patient base in emerging regional economies, along with rising healthcare expenditures. For instance, according to the International Federation for Spina Bifida and Hydrocephalus, over 375,000 new cases of infant hydrocephalus are reported in sub-Saharan Africa each year.
In addition, the incidence rate of road accidents in the MEA economies is rising at an alarming pace and is now the leading cause of mortality among young adults, which is expected to drive regional market demand for external ventricular drains during the forecast period. As per a WHO report, a road-traffic mortality rate of 26.6 deaths per 100,000 people has been registered in the African continent alone.
Key companies are adopting various strategies, such as strategic collaborations and new product launches, to increase their market share and expand their global presence. For instance, in June 2023, the German healthcare company SHS Capital sold its Spiegelberg shares to Luciole Medical AG, a medical technology company dealing in specialized catheters and measuring probes for neurosurgical applications.
Medtronic’s Duet External Drainage and Monitoring System is an innovative product for managing short-term external cerebrospinal fluid (CSF) drainage, allowing caregivers to drain and monitor CSF from ventricular or lumbar areas. Similarly, the company’s VentriClear External Ventricular Drainage (EVD) Catheter Set enables external access and drainage of cerebrospinal fluid from brain ventricles. It uses translucent silicone elastomer with minocycline and rifampin to inhibit bacterial colonization.
In December 2018, Medtronic completed the acquisition of the Israeli company Mazor Robotics, in a transaction valued at USD 1.7 billion. Mazor Robotics will become a part of Medtronic’s Neurosurgery business under the Restorative Therapies Group’s Brain Therapies division. This development is expected to boost the company’s revenue and global presence in the coming years.
Companies are engaging in partnerships, acquisitions, and mergers and aiming to strengthen their product portfolio and manufacturing capacities and provide competitive diversity. For instance, in July 2019, Integra LifeSciences acquired Arkis Biosciences Inc., which was a notable developer and provider of neurosurgical devices. This acquisition has boosted the company’s offerings in neurocritical care. Some of the prominent players in the global external ventricular drain market include:
Spiegelberg GmbH & Co. KG
Möller Medical GmbH
B. Braun SE
Market size value in 2023
USD 7.03 billion
Revenue forecast in 2030
USD 10.52 billion
CAGR of 5.9% from 2023 to 2030
Base year for estimation
2018 - 2021
2023 - 2030
Revenue in USD million/billion and CAGR from 2023 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Application, patient type, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
Spiegelberg GmbH & Co. KG; Medtronic; Sophysa; Neuromedex GmbH; Integra LifeSciences; Möller Medical GmbH; B. Braun SE; Fuji Systems
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global external ventricular drain market report on the basis of patient type, application, and region:.
Application Outlook (Revenue, USD Million, 2018 - 2030)
Traumatic Brain Injury
Other Non-traumatic Hydrocephalus Conditions
Patient Type Outlook (Revenue, USD Million, 2018 - 2030)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
Middle East and Africa
b. The global external ventricular drain market size was estimated at USD 6.5 billion in 2022 and is expected to reach USD 7.03 billion in 2023.
b. The global external ventricular drain market is expected to grow at a compound annual growth rate of 5.9% from 2023 to 2030 to reach USD 10.52 billion by 2030.
b. North America dominated the external ventricular drain market with a share of 35.4% in 2022. This is attributable to the rising incidence of brain-related injuries, the presence of key players in the region, and the well-established healthcare infrastructure in this region.
b. Some key players operating in the external ventricular drain market include Spiegelberg GmbH & Co. KG, Medtronic, Sophysa, Dispomedica GmbH, Integra LifeSciences, Möller Medical GmbH, B. Braun Melsungen AG and Fuji Systems.
b. Key factors driving the external ventricular drain market growth include a high prevalence of cerebrovascular disorders such as intraventricular or subarachnoid hemorrhages, intracranial hypertension, hydrocephalus, and inflammatory diseases in the brain, as well as rising cranial injuries and trauma.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."